Martel-Pelletier, J. et al. Osteoarthritis. Nat Rev Dis Primers 2, 16072, https://doi.org/10.1038/nrdp.2016.72 (2016).
Arden, N. & Nevitt, M. C. Osteoarthritis: epidemiology. Best Pract Res Clin Rheumatol 20, 3–25 (2006).
2018 World Population Data Sheet, https://www.prb.org/wp-content/uploads/2018/08/2018_WPDS.pdf (2018).
Stephen, J. M. et al. The infrapatellar fat pad is a dynamic and mobile structure, which deforms during knee motion, and has proximal extensions which wrap around the patella. Knee Surg Sports Traumatol Arthrosc 26, 3515–3524, https://doi.org/10.1007/s00167-018-4943-1 (2018).
Davis, J. E. et al. Effusion-synovitis and infrapatellar fat pad signal intensity alteration differentiate accelerated knee osteoarthritis. Rheumatology (Oxford) 58, 418–426, https://doi.org/10.1093/rheumatology/key305 (2019).
Masaki, T. et al. Volume change in infrapatellar fat pad is associated not with obesity but with cartilage degeneration. J Orthop Res 37, 593–600, https://doi.org/10.1002/jor.24201 (2019).
Harkey, M. S. et al. Early pre-radiographic structural pathology precedes the onset of accelerated knee osteoarthritis. BMC Musculoskelet Disord 20, 241, https://doi.org/10.1186/s12891-019-2624-y (2019).
Wang, K. et al. Signal intensity alteration within infrapatellar fat pad predicts knee replacement within 5 years: data from the Osteoarthritis Initiative. Osteoarthritis Cartilage 26, 1345–1350, https://doi.org/10.1016/j.joca.2018.05.015 (2018).
Ruhdorfer, A. et al. Between-group differences in infra-patellar fat pad size and signal in symptomatic and radiographic progression of knee osteoarthritis vs non-progressive controls and healthy knees – data from the FNIH Biomarkers Consortium Study and the Osteoarthritis Initiative. Osteoarthritis Cartilage 25, 1114–1121, https://doi.org/10.1016/j.joca.2017.02.789 (2017).
Martel-Pelletier, J., Raynauld, J. P., Dorais, M., Abram, F. & Pelletier, J. P. The levels of the adipokines adipsin and leptin are associated with knee osteoarthritis progression as assessed by MRI and incidence of total knee replacement in symptomatic osteoarthritis patients: a post hoc analysis. Rheumatology (Oxford) 55, 680–688, https://doi.org/10.1093/rheumatology/kev408 (2016).
Conde, J. et al. Differential expression of adipokines in infrapatellar fat pad (IPFP) and synovium of osteoarthritis patients and healthy individuals. Ann Rheum Dis 73, 631–633, https://doi.org/10.1136/annrheumdis-2013-204189 (2014).
Martel-Pelletier, J. et al. The ratio adipsin/MCP-1 is strongly associated with structural changes and CRP/MCP-1 with symptoms in obese knee osteoarthritis subjects: data from the Osteoarthritis Initiative. Osteoarthritis Cartilage 28, 1163–1173, https://doi.org/10.1016/j.joca.2019.04.016 (2019).
Sarray, S., Madan, S., Saleh, L. R., Mahmoud, N. & Almawi, W. Y. Validity of adiponectin-to-leptin and adiponectin-to-resistin ratios as predictors of polycystic ovary syndrome. Fertil Steril 104, 460–466, https://doi.org/10.1016/j.fertnstert.2015.05.007 (2015).
Gandhi, R., Takahashi, M., Smith, H., Rizek, R. & Mahomed, N. N. The synovial fluid adiponectin-leptin ratio predicts pain with knee osteoarthritis. Clin Rheumatol 29, 1223–1228, https://doi.org/10.1007/s10067-010-1429-z (2010).
Rueda-Clausen, C. F. et al. The presence of abdominal obesity is associated with changes in vascular function independently of other cardiovascular risk factors. Int J Cardiol 139, 32–41, https://doi.org/10.1016/j.ijcard.2008.09.005 (2010).
Galluccio, E. et al. Hyperinsulinemia and impaired leptin-adiponectin ratio associate with endothelial nitric oxide synthase polymorphisms in subjects with in-stent restenosis. Am J Physiol Endocrinol Metab 294, E978–986, https://doi.org/10.1152/ajpendo.00003.2008 (2008).
Oda, N. et al. The ratio of leptin to adiponectin can be used as an index of insulin resistance. Metabolism 57, 268–273, https://doi.org/10.1016/j.metabol.2007.09.011 (2008).
Norata, G. D. et al. Leptin:adiponectin ratio is an independent predictor of intima media thickness of the common carotid artery. Stroke 38, 2844–2846, https://doi.org/10.1161/STROKEAHA.107.485540 (2007).
Satoh, N. et al. Leptin-to-adiponectin ratio as a potential atherogenic index in obese type 2 diabetic patients. Diabetes Care 27, 2488–2490 (2004).
Peterfy, C. G., Schneider, E. & Nevitt, M. The osteoarthritis initiative: report on the design rationale for the magnetic resonance imaging protocol for the knee. Osteoarthritis Cartilage 16, 1433–1441, https://doi.org/10.1016/j.joca.2008.06.016 (2008).
Iglesias, J. E. & Sabuncu, M. R. Multi-atlas segmentation of biomedical images: A survey. Medical image analysis 24, 205–219, https://doi.org/10.1016/j.media.2015.06.012 (2015).
Long, J., Shelhamer, E. & Darrell, T. Fully convolutional networks for semantic segmentation. IEEE Conference on Computer Vision and Pattern Recognition (CVPR), Boston, MA, 2015, pp. 3431–3440., https://doi.org/10.1109/CVPR.2015.7298965 (2015).
Ronneberger, O., Fischer, P. & Brox, T. In Medical Image Computing and Computer-Assisted Intervention – MICCAI 2015. LNCS Vol. 9351 (eds N. Navab, J. Hornegger, W.M. Wells, & A.F. Frangi) 234-241 (Springer, 2015).
Xiong, B. L., Huang, Y., Shi, M., Du, W. & Yang, M. Y. Feature selection of input variables for intelligence joint moment prediction based on binary particle swarm optimization. IEEE Access 7, 182289–182295 (2019).
Sakri, S. B. R. N.B.A.; Zain, Z.M. Particle swarm optimization feature selection for breast cancer recurrence prediction. IEEE Access 6, 29637–29647 (2018).
Shilaskar, S. G. & Chatur, A. P. Medical decision support system for extremely imbalanced datasets. Inform Sciences 384, 205–219 (2017).
Sharkawy, R. M. I., Salama, K. & Bartnikas, M. M. A. R. Particle swarm optimization feature selection for the classification of conducting particles in transformer oil. IEEE Trans Dielectr Electr Insul 18, 1897–1907 (2011).
Zhu, Q. Q. L., Li, Y. & Zhu, S. An improved particle swarm optimization algorithm for vehicle routing problem with time windows. IEEE International Conference on Evolutionary Computation, 1386–1390 (2006).
Moradi, F. et al. Abutment scour depth modeling using neuro-fuzzy-embedded techniques. Mar Georesour Geotec 37, 190–200, https://doi.org/10.1080/1064119X.2017.1420113 (2019).
Azimi, H., Bonakdari, H. & Ebtehaj, I. A highly efficient gene expression programming model for predicting the discharge coefficient in a side weir along a trapezoidal canal. Irrig. Drain 66, 655–666, https://doi.org/10.1002/ird.2127 (2017).
Raynauld, J. P. et al. Protective effects of licofelone, a 5-lipoxygenase and cyclo-oxygenase inhibitor, versus naproxen on cartilage loss in knee osteoarthritis: a first multicentre clinical trial using quantitative MRI. Ann Rheum Dis 68, 938–947, https://doi.org/10.1136/ard.2008.088732 (2009).
Krysiak, R., Handzlik-Orlik, G. & Okopien, B. The role of adipokines in connective tissue diseases. Eur J Nutr 51, 513–528, https://doi.org/10.1007/s00394-012-0370-0 (2012).
Shehzad, A., Iqbal, W., Shehzad, O. & Lee, Y. S. Adiponectin: regulation of its production and its role in human diseases. Hormones (Athens) 11, 8–20 (2012).
Neumeier, M. et al. Different effects of adiponectin isoforms in human monocytic cells. J Leukoc Biol 79, 803–808, https://doi.org/10.1189/jlb.0905521 (2006).
Diepold, J. et al. Sex-differences of the healthy infra-patellar (Hoffa) fat pad in relation to intermuscular and subcutaneous fat content–data from the Osteoarthritis Initiative. Ann Anat 200, 30–36, https://doi.org/10.1016/j.aanat.2014.12.004 (2015).
Teichtahl, A. J. et al. A large infrapatellar fat pad protects against knee pain and lateral tibial cartilage volume loss. Arthritis Res Ther 17, 318, https://doi.org/10.1186/s13075-015-0831-y (2015).
Han, W. et al. Infrapatellar fat pad in the knee: is local fat good or bad for knee osteoarthritis? Arthritis Res Ther 16, R145, https://doi.org/10.1186/ar4607 (2014).
Burda, B. et al. Variance in infra-patellar fat pad volume: Does the body mass index matter?-Data from osteoarthritis initiative participants without symptoms or signs of knee disease. Ann Anat 213, 19–24, https://doi.org/10.1016/j.aanat.2017.04.004 (2017).
Chuckpaiwong, B., Charles, H. C., Kraus, V. B., Guilak, F. & Nunley, J. A. Age-associated increases in the size of the infrapatellar fat pad in knee osteoarthritis as measured by 3T MRI. J Orthop Res 28, 1149–1154, https://doi.org/10.1002/jor.21125 (2010).
Valverde-Franco, G. et al. High in vivo levels of adipsin lead to increased knee tissue degradation in osteoarthritis: data from humans and animal models. Rheumatology (Oxford) 57, 1851–1860, https://doi.org/10.1093/rheumatology/key181 (2018).
Lo, J. C. et al. Adipsin is an adipokine that improves beta cell function in diabetes. Cell 158, 41–53, https://doi.org/10.1016/j.cell.2014.06.005 (2014).
White, R. T. et al. Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue. J Biol Chem 267, 9210–9213 (1992).
Mariani, F. & Roncucci, L. Chemerin/chemR23 axis in inflammation onset and resolution. Inflamm Res 64, 85–95, https://doi.org/10.1007/s00011-014-0792-7 (2015).
Berg, V. et al. Human articular chondrocytes express ChemR23 and chemerin; ChemR23 promotes inflammatory signalling upon binding the ligand chemerin(21-157). Arthritis Res Ther 12, R228, https://doi.org/10.1186/ar3215 (2010).
Tolusso, B. et al. Chemerin and PEDF Are Metaflammation-Related Biomarkers of Disease Activity and Obesity in Rheumatoid Arthritis. Front Med (Lausanne) 5, 207, https://doi.org/10.3389/fmed.2018.00207 (2018).
Chen, T. H. et al. Evidence for a protective role for adiponectin in osteoarthritis. Biochim Biophys Acta 1762, 711–718, https://doi.org/10.1016/j.bbadis.2006.06.008 (2006).
Chu, S. H. et al. Chemerin and adiponectin contribute reciprocally to metabolic syndrome. PLoS One 7, e34710, https://doi.org/10.1371/journal.pone.0034710 (2012).
Lee, B. J., Yang, S., Kwon, S., Choi, K. H. & Kim, W. Association between metabolic syndrome and knee osteoarthritis: A cross-sectional nationwide survey study. J Rehabil Med 51, 464–470, https://doi.org/10.2340/16501977-2561 (2019).
Pan, F., Tian, J., Mattap, S. M., Cicuttini, F. & Jones, G. Association between metabolic syndrome and knee structural change on MRI. Rheumatology (Oxford), https://doi.org/10.1093/rheumatology/kez266 (2019).
Matsukawa, A. et al. Neutrophil accumulation and activation by homologous IL-8 in rabbits. IL-8 induces destruction of cartilage and production of IL-1 and IL-1 receptor antagonist in vivo. J Immunol 154, 5418–5425 (1995).
Baggiolini, M., Walz, A. & Kunkel, S. L. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 84, 1045–1049, https://doi.org/10.1172/JCI114265 (1989).
Hulejova, H. et al. Increased level of cytokines and matrix metalloproteinases in osteoarthritic subchondral bone. Cytokine 38, 151–156, https://doi.org/10.1016/j.cyto.2007.06.001 (2007).
Kaneko, S. et al. Interleukin-6 and interleukin-8 levels in serum and synovial fluid of patients with osteoarthritis. Cytokines Cell Mol Ther 6, 71–79, https://doi.org/10.1080/13684730050515796 (2000).
Ruan, G. et al. Associations between serum IL-8 and knee symptoms, joint structures, and cartilage or bone biomarkers in patients with knee osteoarthritis. Clin Rheumatol 38, 3609–3617, https://doi.org/10.1007/s10067-019-04718-8 (2019).
Han, W. et al. Association Between Quantitatively Measured Infrapatellar Fat Pad High Signal-Intensity Alteration and Magnetic Resonance Imaging-Assessed Progression of Knee Osteoarthritis. Arthritis Care Res (Hoboken) 71, 638–646, https://doi.org/10.1002/acr.23713 (2019).
Han, W. et al. Hypointense signals in the infrapatellar fat pad assessed by magnetic resonance imaging are associated with knee symptoms and structure in older adults: a cohort study. Arthritis Res Ther 18, 234, https://doi.org/10.1186/s13075-016-1130-y (2016).
Han, W. et al. Signal intensity alteration in the infrapatellar fat pad at baseline for the prediction of knee symptoms and structure in older adults: a cohort study. Ann Rheum Dis 75, 1783–1788, https://doi.org/10.1136/annrheumdis-2015-208360 (2016).